&gt;b&lt;Epidemiology and economics of mastitis in smallholders dairy farms in southeast of Brazil&gt;/b&lt;

Silva, Aline Callegari

doi:10.11606/t.10.2020.tde-06052021-100703

Cited by 1 publication

(1 citation statement)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, breeding goals for pigs include not only such core traits as average daily gain and feed conversion, but also disease resistance or resilience and lessened antibiotic usage, heat tolerance, nutrient utilization, welfare, behavior, and meat quality (Paustian 2022); further, functional annotation of the porcine genome (Pan et al 2021) contributes to trait discovery and more rapid genetic progress. Recent livestock breeding has incorporated selection for molecular markers linked to quantitative trait loci and genome-enabled selection (Meuwissen et al 2001), increasing the rate of genetic gain, as exemplified by dairy cattle in the United States (Wiggans et al 2017) and Brazil (Boison et al 2017;Verardo et al 2021;Silva 2022) and zebu beef cattle in Brazil (Chiaia et al 2017;Brito Lopes et al 2020;Baldi 2022). Genomic approaches are being applied to identify variants promoting adaptation or increasing performance of livestock under specific environmental conditions (Ortega 2022).…”

Section: Building Upon Classical Selective Breedingmentioning

confidence: 99%

Enabling regulatory policy globally will promote realization of the potential of animal biotechnology

Hallerman,

Bredlau,

Camargo

et al. 2024

CABI Agric Biosci

View full text Add to dashboard Cite

Animal biotechnologies have the potential to improve the sustainability and security of our global food systems. Government regulatory authorities are responsible for ensuring the safety of food their citizens consume, whether it is produced via conventional breeding methods or biotechnologies. While some countries have implemented animal biotechnology oversight policies, many countries have yet to develop theirs. Historically, regulatory approvals were required before products of biotechnology could enter the marketplace, and the high cost of the approval process limited the number and types of animal and plant products that sought approval. Only one biotech animal in the world that was developed for food production has reached the market under a GMO or rDNA approval process. The advent of genome editing techniques has revolutionized the scientific approach to introducing changes into DNA sequences and how biotechnology can be used to enhance agricultural breeding. Regulatory dialogs about biotechnology also have changed as a result of these new technologies. Regulatory agencies have begun to respond to these scientific advances, and a growing number of countries are looking to modernize regulatory approaches for these products, based on risk (or lack thereof) and similarity to organisms that could be produced via conventional breeding methods. Advances in animal biotechnology, especially genome editing, can accelerate the incorporation of valued phenotypes in animals, including enhanced yield, disease resistance, resilience to changing climate, and improved animal welfare, as well as food qualities valued by consumers. For animals with these biotechnology-introduced traits to enter agricultural production and reach consumers, clear risk-proportionate regulatory approaches must be in place, and to facilitate international trade of animal products, regulatory processes need to be aligned and compatible. Effective scientific public communication is crucial to build public trust in precision animal biotechnology and risk-proportionate regulatory approaches. An international workshop on regulatory approaches for animal biotechnology was convened in 2022 with 27 countries represented. We synthesize here technical progress, development of regulatory policy, and strategies for engagement with diverse publics on animal biotechnology reported in the workshop. Our goal is to encourage development and implementation of risk-proportionate regulatory approaches and policies in a global context.

show abstract

Section: Building Upon Classical Selective Breedingmentioning

confidence: 99%

Enabling regulatory policy globally will promote realization of the potential of animal biotechnology

Hallerman,

Bredlau,

Camargo

et al. 2024

CABI Agric Biosci

View full text Add to dashboard Cite

show abstract

>b<Epidemiology and economics of mastitis in smallholders dairy farms in southeast of Brazil>/b<

Abstract: Palavras-chave: Fatores de risco. Custo da Mastite. Economia da saúde animal. Medidas preventivas. Transição para orgânico.

Cited by 1 publication

References 50 publications

Enabling regulatory policy globally will promote realization of the potential of animal biotechnology

Enabling regulatory policy globally will promote realization of the potential of animal biotechnology

Contact Info

Product

Resources

About